Filtered By:
Therapy: Immunotherapy
Vaccination: Measles Vaccine

This page shows you your search results in order of date.

Order by Relevance | Date

Total 2 results found since Jan 2013.

Gene Therapy Leaves a Vicious Cycle
Reena Goswami1, Gayatri Subramanian2, Liliya Silayeva1, Isabelle Newkirk1, Deborah Doctor1, Karan Chawla2, Saurabh Chattopadhyay2, Dhyan Chandra3, Nageswararao Chilukuri1 and Venkaiah Betapudi1,4* 1Neuroscience Branch, Research Division, United States Army Medical Research Institute of Chemical Defense, Aberdeen, MD, United States 2Department of Medical Microbiology and Immunology, University of Toledo College of Medicine and Life Sciences, Toledo, OH, United States 3Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States 4Department of Physiology and Biophysics, Case Western Reserve University, Clev...
Source: Frontiers in Oncology - April 23, 2019 Category: Cancer & Oncology Source Type: research

Two‐year experience of using the measles, mumps and rubella vaccine as intralesional immunotherapy for warts
ConclusionsWe suggest that intralesional immunotherapy with MMR vaccine is a tolerable and effective method for patients who are sensitive to pain, concerned about side effects, or have common warts. Treatment response is improved by increasing the number of injections.
Source: Clinical And Experimental Dermatology - June 16, 2014 Category: Dermatology Authors: C. H. Na, H. Choi, S. H. Song, M. S. Kim, B. S. Shin Tags: Clinical dermatology ● Original article Source Type: research